Breast cancer trial tests treatment swap strategy to outsmart tumor resistance
NCT ID NCT07455188
Summary
This study aims to see if switching between two different targeted drug combinations helps control advanced HER2-positive breast cancer for a longer time after the first treatment stops working. It will involve 600 women whose cancer has spread and who have already tried one of these drug combinations. Researchers will compare which order of using these treatments works better to delay cancer growth and extend survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhejiang Cancer Hospital
RECRUITINGZhejiang, Hangzhou, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.